MiMedx Group (MDXG) Reports In-Line Q3 EPS

MiMedx Group (NASDAQ: MDXG) reported Q3 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $81.71 million versus the consensus estimate of $76.79 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
• Astrana Health (ASTH) Mentioned as short at Glass House